Table 1:
Common gene variants associated with hereditary ATTR amyloidosis
| Val122Ile | Thr60Ala | Val30Met | IIe68Leu | Leu111Met | |
|---|---|---|---|---|---|
| Prevalence | 3–4% of African Americans | 1% North-west Republic of Ireland | Most common world-wide mutation, varies depending on country, can approach 1:1000 in endemic areas | Unknown | Unknown |
| Presenting age (median) | >65 years | >60 years | 30–40 years in endemic areas, 50–60 years in non-endemic areas. | >60 years | >30 years |
| Male: Female | 3:1 | unknown | 2:1 | Male predominance in affected patients, but not in mutation carriers | unknown |
| Ethnicity | African/Afro-Caribbean | Caucasian | Any | Caucasian | Danish |
| Geographical distribution | USA, Caribbean, Africa | USA, Ireland, Germany, England | Sweden, France, Portugal, Japan | Central-northern Italy | Denmark |
| Cardiac Phenotype | Cardiac involvement always present | Cardiac involvement in 42% of patients | Cardiac involvement is rare, more in late-onset cases (conduction disease more common) | Cardiac involvement nearly always present | Cardiac involvement always present |
| Extra-cardiac manifestations | PN (10%) and CTS | AN is common, PN is less common | PN and AN are common | CTS is common (42%), PN is less common (<10%) | CTS is common |
AN, autonomic neuropathy; CM, cardiomyopathy; CTS, carpal tunnel syndrome; PN, peripheral neuropathy; THAOS, Transthyretin Amyloid Outcome Survey.